These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 36224265)

  • 1. CRISPR-Cas9 hits its target in amyloidosis.
    Carvalho T
    Nat Med; 2022 Dec; 28(12):2438. PubMed ID: 36224265
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid genome editing by CRISPR-Cas9-POLD3 fusion.
    Reint G; Li Z; Labun K; Keskitalo S; Soppa I; Mamia K; Tolo E; Szymanska M; Meza-Zepeda LA; Lorenz S; Cieslar-Pobuda A; Hu X; Bordin DL; Staerk J; Valen E; Schmierer B; Varjosalo M; Taipale J; Haapaniemi E
    Elife; 2021 Dec; 10():. PubMed ID: 34898428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome editing: A perspective on the application of CRISPR/Cas9 to study human diseases (Review).
    Rodríguez-Rodríguez DR; Ramírez-Solís R; Garza-Elizondo MA; Garza-Rodríguez ML; Barrera-Saldaña HA
    Int J Mol Med; 2019 Apr; 43(4):1559-1574. PubMed ID: 30816503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marker-free genome editing in Ustilago trichophora with the CRISPR-Cas9 technology.
    Huck S; Bock J; Girardello J; Gauert M; Pul Ü
    RNA Biol; 2019 Apr; 16(4):397-403. PubMed ID: 29996713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sharpening the Scissors: Mechanistic Details of CRISPR/Cas9 Improve Functional Understanding and Inspire Future Research.
    Raper AT; Stephenson AA; Suo Z
    J Am Chem Soc; 2018 Sep; 140(36):11142-11152. PubMed ID: 30160947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9 in plants: at play in the genome and at work for crop improvement.
    Hussain B; Lucas SJ; Budak H
    Brief Funct Genomics; 2018 Sep; 17(5):319-328. PubMed ID: 29912293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response.
    Haapaniemi E; Botla S; Persson J; Schmierer B; Taipale J
    Nat Med; 2018 Jul; 24(7):927-930. PubMed ID: 29892067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanding the scope of CRISPR/Cas9-mediated genome editing in plants using an xCas9 and Cas9-NG hybrid.
    Niu Q; Wu S; Li Y; Yang X; Liu P; Xu Y; Lang Z
    J Integr Plant Biol; 2020 Apr; 62(4):398-402. PubMed ID: 31702097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant Tissue Culture: A Battle Horse in the Genome Editing Using CRISPR/Cas9.
    Loyola-Vargas VM; Avilez-Montalvo RN
    Methods Mol Biol; 2018; 1815():131-148. PubMed ID: 29981117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanding the target range of base editing in plants without loss of efficiency by blocking RNA-silencing.
    Mao Y; Wang M; Zhao Y; Huang B; Wu Q; Zheng Q; Botella JR; Zhu JK
    Plant Biotechnol J; 2021 Dec; 19(12):2389-2391. PubMed ID: 34555248
    [No Abstract]   [Full Text] [Related]  

  • 11. Spatial control of in vivo CRISPR-Cas9 genome editing via nanomagnets.
    Zhu H; Zhang L; Tong S; Lee CM; Deshmukh H; Bao G
    Nat Biomed Eng; 2019 Feb; 3(2):126-136. PubMed ID: 30944431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interpretable model of CRISPR-Cas9 enzymatic reactions.
    Wen DJ; Theodoris CV
    Nat Comput Sci; 2023 Dec; 3(12):1011-1012. PubMed ID: 38177728
    [No Abstract]   [Full Text] [Related]  

  • 13. Conditional CRISPR-Cas Genome Editing in
    Bahuguna S; Redhai S; Zhou J; Wang T; Port F; Boutros M
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient genome editing in wheat using Cas9 and Cpf1 (AsCpf1 and LbCpf1) nucleases.
    Kim D; Hager M; Brant E; Budak H
    Funct Integr Genomics; 2021 Jul; 21(3-4):355-366. PubMed ID: 33710467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulating CRISPR/Cas9 genome-editing activity by small molecules.
    Chen S; Chen D; Liu B; Haisma HJ
    Drug Discov Today; 2022 Apr; 27(4):951-966. PubMed ID: 34823004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 for the Treatment of Transthyretin Cardiac Amyloidosis.
    Panichella G; Aimo A
    Curr Pharm Des; 2023; 29(39):3166-3169. PubMed ID: 38058090
    [No Abstract]   [Full Text] [Related]  

  • 17. Rock paper scissors: CRISPR/Cas9-mediated interference with geminiviruses in plants.
    Yang X; Zhou H; Zhou X
    Sci China Life Sci; 2019 Oct; 62(10):1389-1391. PubMed ID: 31571024
    [No Abstract]   [Full Text] [Related]  

  • 18. Carboxylated nanodiamond-mediated CRISPR-Cas9 delivery of human retinoschisis mutation into human iPSCs and mouse retina.
    Yang TC; Chang CY; Yarmishyn AA; Mao YS; Yang YP; Wang ML; Hsu CC; Yang HY; Hwang DK; Chen SJ; Tsai ML; Lai YH; Tzeng Y; Chang CC; Chiou SH
    Acta Biomater; 2020 Jan; 101():484-494. PubMed ID: 31672582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR/Cas9-based epigenome editing: An overview of dCas9-based tools with special emphasis on off-target activity.
    Tadić V; Josipović G; Zoldoš V; Vojta A
    Methods; 2019 Jul; 164-165():109-119. PubMed ID: 31071448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR/Cas9 gene editing in the West Nile Virus vector, Culex quinquefasciatus Say.
    Anderson ME; Mavica J; Shackleford L; Flis I; Fochler S; Basu S; Alphey L
    PLoS One; 2019; 14(11):e0224857. PubMed ID: 31714905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.